Jonathan D Zurawski, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Sclerosis | 13 | 2022 | 2934 | 1.910 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 5 | 2022 | 506 | 1.400 |
Why?
|
Meninges | 2 | 2019 | 177 | 1.240 |
Why?
|
Meningitis | 1 | 2017 | 227 | 0.550 |
Why?
|
Tolosa-Hunt Syndrome | 1 | 2013 | 2 | 0.520 |
Why?
|
Immunologic Factors | 3 | 2020 | 1578 | 0.490 |
Why?
|
Drug Substitution | 1 | 2016 | 284 | 0.480 |
Why?
|
Ophthalmoplegia | 1 | 2013 | 169 | 0.450 |
Why?
|
Rare Diseases | 1 | 2013 | 509 | 0.350 |
Why?
|
Disability Evaluation | 4 | 2020 | 1829 | 0.330 |
Why?
|
Headache | 1 | 2013 | 1109 | 0.290 |
Why?
|
Cognition Disorders | 1 | 2020 | 3956 | 0.280 |
Why?
|
Quality of Life | 4 | 2021 | 11594 | 0.270 |
Why?
|
Severity of Illness Index | 2 | 2020 | 16008 | 0.250 |
Why?
|
Disease Progression | 2 | 2021 | 13298 | 0.240 |
Why?
|
Magnetic Resonance Imaging | 7 | 2022 | 34151 | 0.210 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 1 | 2021 | 212 | 0.180 |
Why?
|
Atrophy | 2 | 2022 | 1509 | 0.170 |
Why?
|
Brain | 4 | 2022 | 24969 | 0.160 |
Why?
|
Interferon-beta | 1 | 2018 | 326 | 0.150 |
Why?
|
Computers | 1 | 2018 | 597 | 0.150 |
Why?
|
Longitudinal Studies | 3 | 2019 | 13536 | 0.130 |
Why?
|
Vaccines | 1 | 2022 | 719 | 0.130 |
Why?
|
Risk Assessment | 1 | 2016 | 23284 | 0.130 |
Why?
|
Meningitis, Aseptic | 1 | 2014 | 68 | 0.130 |
Why?
|
Social Stigma | 1 | 2020 | 643 | 0.120 |
Why?
|
Middle Aged | 12 | 2022 | 213752 | 0.120 |
Why?
|
Cytoskeletal Proteins | 2 | 2010 | 1421 | 0.120 |
Why?
|
Cavernous Sinus | 1 | 2013 | 127 | 0.110 |
Why?
|
Adult | 11 | 2022 | 211041 | 0.110 |
Why?
|
Recurrence | 3 | 2022 | 8255 | 0.100 |
Why?
|
Vasoconstriction | 1 | 2014 | 610 | 0.100 |
Why?
|
Intracellular Fluid | 1 | 2010 | 214 | 0.100 |
Why?
|
Growth Cones | 1 | 2010 | 121 | 0.100 |
Why?
|
Myelin Proteins | 1 | 2010 | 214 | 0.100 |
Why?
|
Statistics, Nonparametric | 1 | 2016 | 2945 | 0.100 |
Why?
|
Diagnosis, Differential | 2 | 2017 | 13274 | 0.100 |
Why?
|
Posterior Horn Cells | 1 | 2010 | 82 | 0.100 |
Why?
|
Female | 14 | 2022 | 375205 | 0.090 |
Why?
|
Neural Inhibition | 2 | 2010 | 592 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4254 | 0.090 |
Why?
|
Prednisone | 1 | 2013 | 1556 | 0.090 |
Why?
|
Humans | 19 | 2022 | 708843 | 0.090 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2010 | 3026 | 0.090 |
Why?
|
Glucocorticoids | 1 | 2017 | 2125 | 0.080 |
Why?
|
Male | 10 | 2022 | 349524 | 0.080 |
Why?
|
Pruritus | 1 | 2010 | 334 | 0.080 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2019 | 3418 | 0.070 |
Why?
|
Vision Disorders | 1 | 2013 | 1038 | 0.070 |
Why?
|
Administration, Oral | 1 | 2013 | 3944 | 0.070 |
Why?
|
Interneurons | 1 | 2010 | 577 | 0.070 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9584 | 0.070 |
Why?
|
Drug Administration Schedule | 1 | 2013 | 5045 | 0.070 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4226 | 0.060 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2010 | 1146 | 0.060 |
Why?
|
Glia Maturation Factor | 1 | 2022 | 15 | 0.060 |
Why?
|
Cerebrovascular Circulation | 1 | 2014 | 2748 | 0.060 |
Why?
|
Anti-Inflammatory Agents | 1 | 2013 | 1805 | 0.060 |
Why?
|
Databases, Factual | 1 | 2019 | 7763 | 0.060 |
Why?
|
Muromonab-CD3 | 1 | 2022 | 107 | 0.060 |
Why?
|
Cognition | 1 | 2020 | 5982 | 0.060 |
Why?
|
Phenotype | 1 | 2020 | 16306 | 0.060 |
Why?
|
Antigens, CD20 | 1 | 2022 | 211 | 0.050 |
Why?
|
Administration, Intranasal | 1 | 2022 | 444 | 0.050 |
Why?
|
Research Subjects | 1 | 2022 | 247 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2013 | 11239 | 0.050 |
Why?
|
Retrospective Studies | 4 | 2022 | 71483 | 0.050 |
Why?
|
Axons | 1 | 2008 | 1747 | 0.050 |
Why?
|
Risk Factors | 2 | 2017 | 69553 | 0.050 |
Why?
|
Time Factors | 2 | 2019 | 41038 | 0.050 |
Why?
|
Prognosis | 1 | 2017 | 28919 | 0.040 |
Why?
|
Cohort Studies | 1 | 2019 | 39292 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 17218 | 0.040 |
Why?
|
Fatigue | 1 | 2021 | 1450 | 0.030 |
Why?
|
Microfilament Proteins | 2 | 2010 | 1210 | 0.030 |
Why?
|
Antibodies, Viral | 1 | 2022 | 2930 | 0.030 |
Why?
|
Mice, Neurologic Mutants | 1 | 2010 | 159 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 2864 | 0.020 |
Why?
|
Subcellular Fractions | 1 | 2010 | 576 | 0.020 |
Why?
|
Pilot Projects | 1 | 2022 | 7994 | 0.020 |
Why?
|
Growth Inhibitors | 1 | 2010 | 381 | 0.020 |
Why?
|
Nonmuscle Myosin Type IIA | 1 | 2008 | 27 | 0.020 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2010 | 275 | 0.020 |
Why?
|
Neurons | 1 | 2008 | 9385 | 0.020 |
Why?
|
Stem Cells | 1 | 2022 | 3593 | 0.020 |
Why?
|
Gene Knock-In Techniques | 1 | 2010 | 449 | 0.020 |
Why?
|
Genetic Complementation Test | 1 | 2008 | 586 | 0.020 |
Why?
|
Two-Hybrid System Techniques | 1 | 2008 | 484 | 0.020 |
Why?
|
rho-Associated Kinases | 1 | 2008 | 277 | 0.020 |
Why?
|
Signal Transduction | 1 | 2010 | 23950 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2010 | 2877 | 0.020 |
Why?
|
Receptors, Immunologic | 1 | 2010 | 1482 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2022 | 61932 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2008 | 1712 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2010 | 20170 | 0.010 |
Why?
|
Neuronal Plasticity | 1 | 2010 | 1426 | 0.010 |
Why?
|
Spinal Cord | 1 | 2010 | 1831 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2008 | 3972 | 0.010 |
Why?
|
Cell Survival | 1 | 2010 | 6156 | 0.010 |
Why?
|
RNA Interference | 1 | 2008 | 3026 | 0.010 |
Why?
|
Mice | 3 | 2010 | 80876 | 0.010 |
Why?
|
Child | 1 | 2022 | 73636 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2010 | 15274 | 0.010 |
Why?
|
Rats | 1 | 2010 | 25094 | 0.010 |
Why?
|
Animals | 3 | 2010 | 170486 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 2008 | 5703 | 0.010 |
Why?
|
Aged | 1 | 2022 | 161488 | 0.010 |
Why?
|
Young Adult | 1 | 2014 | 55940 | 0.000 |
Why?
|